Trial Profile
Phase I/II Study of EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs EGFR-IL12-CAR-T-cell-therapy-Pregen(ShenZhen)-Biotechnology (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 08 Jun 2018 New trial record